1. Home
  2. CHRS vs LGCY Comparison

CHRS vs LGCY Comparison

Compare CHRS & LGCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • LGCY
  • Stock Information
  • Founded
  • CHRS 2010
  • LGCY 2009
  • Country
  • CHRS United States
  • LGCY United States
  • Employees
  • CHRS N/A
  • LGCY N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • LGCY
  • Sector
  • CHRS Health Care
  • LGCY
  • Exchange
  • CHRS Nasdaq
  • LGCY NYSE
  • Market Cap
  • CHRS 94.0M
  • LGCY 87.3M
  • IPO Year
  • CHRS 2014
  • LGCY 2024
  • Fundamental
  • Price
  • CHRS $0.91
  • LGCY $7.31
  • Analyst Decision
  • CHRS Strong Buy
  • LGCY Strong Buy
  • Analyst Count
  • CHRS 4
  • LGCY 2
  • Target Price
  • CHRS $5.38
  • LGCY $10.65
  • AVG Volume (30 Days)
  • CHRS 2.1M
  • LGCY 28.4K
  • Earning Date
  • CHRS 05-08-2025
  • LGCY 02-13-2025
  • Dividend Yield
  • CHRS N/A
  • LGCY N/A
  • EPS Growth
  • CHRS N/A
  • LGCY 44.62
  • EPS
  • CHRS 0.25
  • LGCY 0.58
  • Revenue
  • CHRS $266,959,999.00
  • LGCY $52,722,310.00
  • Revenue This Year
  • CHRS N/A
  • LGCY $33.77
  • Revenue Next Year
  • CHRS $9.02
  • LGCY $19.89
  • P/E Ratio
  • CHRS $3.66
  • LGCY $12.59
  • Revenue Growth
  • CHRS 3.78
  • LGCY 32.68
  • 52 Week Low
  • CHRS $0.66
  • LGCY $3.60
  • 52 Week High
  • CHRS $2.61
  • LGCY $10.37
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 45.16
  • LGCY N/A
  • Support Level
  • CHRS $0.89
  • LGCY N/A
  • Resistance Level
  • CHRS $1.07
  • LGCY N/A
  • Average True Range (ATR)
  • CHRS 0.09
  • LGCY 0.00
  • MACD
  • CHRS -0.00
  • LGCY 0.00
  • Stochastic Oscillator
  • CHRS 44.79
  • LGCY 0.00

About CHRS Coherus BioSciences Inc.

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

About LGCY LEGACY EDUCATION INC

Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.

Share on Social Networks: